BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11693177)

  • 21. Application of toxicokinetics to improve chemical risk assessment: implications for the use of animals.
    Creton S; Billington R; Davies W; Dent MP; Hawksworth GM; Parry S; Travis KZ
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):291-9. PubMed ID: 19665509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A critical evaluation of developmental and reproductive toxicology in nonhuman primates.
    Faqi AS
    Syst Biol Reprod Med; 2012 Feb; 58(1):23-32. PubMed ID: 22239078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advantages of toxicokinetics in new drug development.
    Horii I
    Toxicol Lett; 1998 Dec; 102-103():657-64. PubMed ID: 10022331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development.
    Halpern WG; Ameri M; Bowman CJ; Elwell MR; Mirsky ML; Oliver J; Regan KS; Remick AK; Sutherland VL; Thompson KE; Tremblay C; Yoshida M; Tomlinson L
    Toxicol Pathol; 2016 Aug; 44(6):789-809. PubMed ID: 27235322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive toxicity testing for pharmaceuticals under ICH.
    Barrow PC
    Reprod Toxicol; 2009 Sep; 28(2):172-9. PubMed ID: 19631153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
    Dixit R; Riviere J; Krishnan K; Andersen ME
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproductive toxicology.
    Brent RL
    Reprod Toxicol; 2010 Apr; 29(2):251-3; author reply 254-5. PubMed ID: 19958827
    [No Abstract]   [Full Text] [Related]  

  • 29. Juvenile animal toxicity study designs to support pediatric drug development.
    Cappon GD; Bailey GP; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Ooshima Y; Stump DG; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):463-9. PubMed ID: 20025047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicology testing in drug discovery and development.
    Dorato MA; Buckley LA
    Curr Protoc Toxicol; 2007 Feb; Chapter 19():Unit19.1. PubMed ID: 23045141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproductive toxicology guidelines: comparison and application.
    Beltrame D; Mazué G
    Ann Ist Super Sanita; 1993; 29(1):3-14. PubMed ID: 8129269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonclinical reproductive toxicity testing requirements for drugs, pesticides, and industrial chemicals in India and China.
    Rao KS; Dong J
    Methods Mol Biol; 2013; 947():13-30. PubMed ID: 23138892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presence of drug in control samples during toxicokinetic investigations--a Novartis perspective.
    Nicholls I; Kolopp M; Pommier F; Scheiwiller M
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):172-8. PubMed ID: 15885865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purpose and guidelines for toxicokinetic studies within the National Toxicology Program.
    Buchanan JR; Burka LT; Melnick RL
    Environ Health Perspect; 1997 May; 105(5):468-71. PubMed ID: 9222127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of a novel integrated toxicity testing strategy incorporating "3R" principles of animal research to evaluate the safety of a new agrochemical sulfoxaflor.
    Terry C; Rasoulpour RJ; Saghir S; Marty S; Gollapudi BB; Billington R
    Crit Rev Toxicol; 2014 May; 44 Suppl 2():1-14. PubMed ID: 24832550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational Safety Genetics.
    Bhoumik P; Del Rio-Espinola A; Hahne F; Moggs J; Grenet O
    Toxicol Pathol; 2017 Jan; 45(1):119-126. PubMed ID: 27932582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An international network (PlaNet) to evaluate a human placental testing platform for chemicals safety testing in pregnancy.
    Brownbill P; Chernyavsky I; Bottalico B; Desoye G; Hansson S; Kenna G; Knudsen LE; Markert UR; Powles-Glover N; Schneider H; Leach L
    Reprod Toxicol; 2016 Sep; 64():191-202. PubMed ID: 27327413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of different generations and developmental stages in studies on reproductive toxicity.
    Schulz F; Batke M; Mangelsdorf I; Pohlenz-Michel C; Simetska N; Lewin G
    Toxicol Lett; 2014 Apr; 226(2):245-55. PubMed ID: 24525464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicokinetics in preclinical evaluation.
    Baldrick P
    Drug Discov Today; 2003 Feb; 8(3):127-33. PubMed ID: 12568782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.